Read + Share
Amedeo Smart
Independent Medical Education
Nguyen AQ, Bednarek N, Al-Sawalha I, Nagele B, et al. Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers. Gynecol Oncol 2026;212:134-144.PMID: 42594534
Email
LinkedIn
Privacy Policy